The medical device business posted gains in many of its key financial metrics, however, the benefits did not carry over to the Atomo Diagnostics share price during trading.
Here’s a rundown of the company’s half-yearly results for the period ending 31 December 2020.
Atomo Diagnostics posts gains across key metrics
The company reported a revenue increase of 389% to $4.58 million for the first half of FY21.
Gross profit was also up, jumping 278% over the prior corresponding period (pcp) to $2.52 million.
Atomo reported a negative net operating cash flow of $193,300 for the period,…